Ryan Owsley, MD
Dermatology · Nampa, IDNPI 1659361681
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 388 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by AbbVie at 33.5% of the total.
Across 388 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$843
- Sun Pharmaceutical Industries Inc.$829
- Novartis$737
- Lilly USA, LLC$476
- UCB, Inc.$456
- plus $3K from 29 others
Across 1 payment — averaging $3916.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Galderma Laboratories, L.p.$4K
What the payments were for
- Food & beverage$8,33295%
- Education$4715%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 125 | $2,946 |
| Johnson & Johnson | 40 | $843 |
| Sun Pharmaceutical Industries Inc. | 50 | $829 |
| Novartis | 28 | $737 |
| Lilly USA, LLC | 14 | $476 |
| UCB, Inc. | 21 | $456 |
| Galderma Laboratories, L.p. | 17 | $394 |
| Regeneron Healthcare Solutions, Inc. | 13 | $345 |
| LEO Pharma Inc. | 9 | $211 |
| Pfizer | 10 | $210 |
| Boehringer Ingelheim | 4 | $186 |
| E.r. Squibb & Sons, L.L.C. | 7 | $124 |
| Merz North America, Inc. | 4 | $113 |
| Mimedx Group, Inc. | 5 | $97 |
| Incyte Corporation | 4 | $80 |
| Acera Surgical, Inc. | 1 | $73 |
| VYNE Pharmaceuticals Inc. | 1 | $72 |
| Arcutis Biotherapeutics, Inc. | 3 | $58 |
| Biofrontera Inc. | 5 | $56 |
| Sanofi | 3 | $54 |
| Regeneron | 1 | $48 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $46 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Kerecis Limited | 3 | $40 |
| Biowound Solutions, Inc. | 3 | $38 |
| Springworks Therapeutics, Inc. | 1 | $33 |
| Prugen, Inc. Pharmaceuticals | 2 | $33 |
| Sandoz | 2 | $28 |
| Genentech USA, Inc. | 2 | $25 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Menarini Silicon Biosystems, Inc. | 1 | $17 |
| Dermira, Inc. | 1 | $15 |
| Organon | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Skyrizi$420
- SIMPONI ARIA$129
- Tremfya$129
How this compares
$8,803 in reported general payments places this provider in the 85th percentile of 52 dermatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 11 | $101,265 |
| Dupixent SyringeDupilumab | 14 | $79,408 |
| OtezlaApremilast | 12 | $59,444 |
| Doxycycline Hyclate | 66 | $2,211 |
| Clobetasol Propionate | 36 | $1,532 |
| Metronidazole | 13 | $1,043 |
| Fluocinolone Acetonide | 14 | $854 |
| Hydroxychloroquine Sulfate | 19 | $718 |
| Spironolactone | 84 | $717 |
| Betamethasone Dipropionate | 13 | $672 |
| MethotrexateMethotrexate Sodium | 31 | $662 |
| ValacyclovirValacyclovir Hcl | 36 | $607 |
| Triamcinolone Acetonide | 52 | $587 |
| Hydrocortisone | 40 | $299 |
| Ketoconazole | 21 | $230 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Nampa
- Ted RyserNampa$5K
- Gavin PowellNampa$3K
- Alan OlmsteadTwin Falls$405K
- Dustin PortelaBoise$164K
- Steven MingsBoise$82K
- Ryan HarrisMeridian$58K
- Jeffrey DraluckNorthbrook$36K
- Mark SchwendimanMeridian$9K
- Kelsey FerrellMeridian$6K
- Nicholas BlickenstaffBoise$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.